Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sanofi SA

54.95
+1.232.29%
Pre-market: 55.000.0500+0.09%08:56 EDT
Volume:1.69M
Turnover:92.35M
Market Cap:134.52B
PE:20.16
High:55.10
Open:55.02
Low:54.30
Close:53.72
Loading ...

Chrissy Teigen - author, entrepreneur, mom to young son with type 1 diabetes - joins Sanofi's Screen For Type 1 movement

PR Newswire
·
15 Apr

Market Chatter: China's New Tariffs to Affect US-Made Drugs, Increase Costs

MT Newswires Live
·
15 Apr

Why You Shouldn't Bet Against Sanofi (SNY) Stock

Zacks
·
11 Apr

This Pharma Giant Will Invest $23 Billion in the U.S. It's a Sign Trump's Tariffs Are Working. -- Barrons.com

Dow Jones
·
11 Apr

Pharma Stocks Surge After Trump's Tariff Pause -- Market Talk

Dow Jones
·
10 Apr

Pharma Stocks Slide Further After Trump Reiterates Tariff Threats on Drugs -- Update

Dow Jones
·
09 Apr

Pharma Stocks Drop After Trump Threatens Tariffs on Medicines -- WSJ

Dow Jones
·
09 Apr

Pharma Stocks Sink After Trump Says "Major" Tariffs Are Coming

Tiger Newspress
·
09 Apr

Trump teases targeted tariffs on overseas drug manufacturers

Dow Jones
·
09 Apr

Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

GlobeNewswire
·
09 Apr

Pharma Stocks Have Risk of U.S. Tariffs Priced In -- Market Talk

Dow Jones
·
08 Apr

Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure

Zacks
·
04 Apr

FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS

Yahoo Finance
·
04 Apr

SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases

Zacks
·
03 Apr

Pharma Stocks Survive Market Rout on Tariff Exemption, but Uncertainty Continues

Reuters
·
03 Apr

NRIX Stock Up as SNY In-Licenses Rights to Autoimmune Diseases Program

Zacks
·
03 Apr

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

Dow Jones
·
03 Apr

Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines

GlobeNewswire
·
03 Apr

Nurix Therapeutics Signs Exclusive Licensing Deal With Sanofi for Autoimmune Disease Program

MT Newswires Live
·
02 Apr

Nurix Therapeutics in Expanded Collaboration with Sanofi

Dow Jones
·
02 Apr